Report structuring
Uploaded blood reports are transformed into structured biomarker records for review.
Team & AI Product Architecture
An AI-native biomarker intelligence platform built for secure digital delivery.
Exia Bio is built as a product system: report intake, AI-assisted structuring, biomarker logic, quality review, and dashboard delivery.
AI-native Workflow
AI is part of the product workflow, not just a marketing label.
The AI layer supports report structuring, data normalization, missing-marker detection, and dashboard preparation. The Sentinel logic layer then organizes biomarker signals into pathway-specific output.
Biomarker normalization
Different report formats are converted into consistent internal records.
Missing-marker detection
The system identifies gaps that limit confidence or require targeted follow-up.
Dashboard generation
Pathway logic and biomarker maps are prepared into dashboard-ready output.
Platform Architecture
A controlled pathway from uploaded report to dashboard release.
This page is intended for high-intent users, partners, and technical reviewers who want to understand how Exia Bio is structured as a repeatable digital product.
01 · Intake
Report and context
User submits report data, pathway selection, and relevant intake context.
02 · Structure
Clean biomarker records
Values, units, dates, and reference intervals are converted into structured records.
03 · Interpret
Sentinel logic layer
Biomarkers are mapped into friction zones, missing signals, and pathway priorities.
04 · Deliver
Secure dashboard
Users receive a dashboard output designed for follow-up and future comparison.
Product Evidence
Dashboard, logic, and product-ready output.
Exia Bio is not presented as a consulting concept. The product is built around a repeatable workflow: uploaded report, structured data, biomarker logic, and dashboard delivery.
Product Interface
Sentinel dashboard preview showing the intended product interface: biomarker interaction map, efficiency score, and optimization priority stack.
Dashboard Output
Current dashboard output preview showing Sentinel Index, constraint classification, and friction-zone logic.
Release Boundary
The platform remains non-diagnostic and educational. Where a result appears outside the context Exia Bio is designed to explain, users are directed to share their original laboratory report and Exia Bio dashboard with a licensed healthcare professional.
Scaling Roadmap
From founder-led launch architecture to global digital delivery.
Exia Bio is designed to begin with controlled launch-stage operations, then expand automation, partner workflows, and continuity tracking as product evidence accumulates.
Launch stage
Manual review and controlled release help protect quality while workflows are validated.
Automation stage
AI-assisted structuring, rule checks, and dashboard generation can be progressively automated.
Scale stage
The same workflow can support regional product pages, partner channels, and continuity-based tracking.